0,651  0,010  5 Hydroxytryptamine release stimulant
0,637  0,031  Caspase 9 stimulant
0,604  0,009  CYP2C19 inhibitor
0,558  0,015  CYP2C9 inhibitor
0,568  0,035  Antineoplastic (lung cancer)
0,504  0,012  CYP3A4 inhibitor
0,504  0,015  CYP2D6 inhibitor
0,481  0,036  Histamine release inhibitor
0,492  0,058  Antineoplastic (solid tumors)
0,441  0,032  Caspase 3 stimulant
0,448  0,052  5 Hydroxytryptamine release inhibitor
0,430  0,035  Antineoplastic (melanoma)
0,415  0,024  Antineoplastic (lymphoma)
0,399  0,031  CYP1A2 inhibitor
0,420  0,061  Prostaglandin dehydrogenase inhibitor
0,391  0,032  Hypoxia-inducible factor 1 alpha inhibitor
0,424  0,066  Calcium channel L-type activator
0,361  0,005  CDC-like kinase 1 inhibitor
0,380  0,031  Antineoplastic (glioblastoma multiforme)
0,381  0,040  Antineoplastic (glioma)
0,376  0,037  Antineoplastic (non-small cell lung cancer)
0,349  0,010  Erectile dysfunction treatment
0,376  0,045  Antineoplastic (brain cancer)
0,344  0,015  Tubulin antagonist
0,352  0,027  Clk dual-specificity kinase inhibitor
0,340  0,018  Male reproductive disfunction treatment
0,324  0,004  Inducible nitric-oxide synthase inhibitor
0,362  0,048  CYP1A2 substrate
0,314  0,015  Neurotrophic factor enhancer
0,360  0,062  Antineoplastic (colorectal cancer)
0,356  0,059  Antineoplastic (colon cancer)
0,335  0,040  Antineoplastic (renal cancer)
0,309  0,014  Phosphodiesterase inhibitor
0,330  0,040  Pyruvate kinase inhibitor
0,332  0,046  Antineoplastic (small cell lung cancer)
0,353  0,070  Angiogenesis inhibitor
0,346  0,074  Antiprotozoal (Plasmodium)
0,300  0,029  5 Hydroxytryptamine 1E antagonist
0,274  0,005  Nitric-oxide synthase inhibitor
0,320  0,052  Huntington's disease treatment
0,302  0,034  Septic shock treatment
0,314  0,048  Cardiodepressant
0,268  0,004  CDC-like kinase 3 inhibitor
0,329  0,067  CYP2D6 substrate
0,311  0,058  Aryl hydrocarbon receptor agonist
0,250  0,004  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,296  0,051  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,316  0,071  12-Lipoxygenase inhibitor
0,263  0,023  Topoisomerase II inhibitor
0,316  0,076  Calcium channel activator
0,295  0,056  Antiprotozoal (Leishmania)
0,266  0,029  Antianorexic
0,251  0,015  5 Hydroxytryptamine 3E antagonist
0,288  0,057  GST M1-1 substrate
0,322  0,092  Antileukemic
0,229  0,005  Phosphodiesterase V inhibitor
0,306  0,082  Vasodilator, coronary
0,295  0,073  Lipoxygenase inhibitor
0,261  0,042  CDC-like kinase 4 inhibitor
0,277  0,060  Dyrk kinase inhibitor
0,274  0,062  Antineoplastic (liver cancer)
0,232  0,020  Topoisomerase I inhibitor
0,309  0,101  CYP2C9 substrate
0,293  0,088  Prostate cancer treatment
0,207  0,004  Phosphodiesterase 11A inhibitor
0,207  0,004  Phosphodiesterase XI inhibitor
0,223  0,022  Phobic disorders treatment
0,205  0,005  Phosphodiesterase 5A inhibitor
0,232  0,032  MAO inhibitor
0,247  0,048  VCAM1 expression inhibitor
0,341  0,144  Apoptosis agonist
0,200  0,006  Alpha tubulin antagonist
0,310  0,117  Antiprotozoal
0,199  0,008  Macrophage migration inhibitory factor inhibitor
0,285  0,095  Antihypertensive
0,311  0,124  15-Lipoxygenase inhibitor
0,270  0,084  Antineoplastic (multiple myeloma)
0,190  0,004  Endothelin receptor antagonist
0,222  0,037  Antineoplastic (squamous cell carcinoma)
0,300  0,119  Antineoplastic (breast cancer)
0,248  0,068  Antineoplastic (lymphocytic leukemia)
0,244  0,067  Cyclic AMP phosphodiesterase inhibitor
0,201  0,025  DNA intercalator
0,280  0,106  Transcription factor NF kappa B inhibitor
0,211  0,041  Antineoplastic (carcinoma)
0,257  0,089  Antineoplastic (ovarian cancer)
0,207  0,039  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,212  0,045  3C-like protease (Human coronavirus) inhibitor
0,246  0,083  Antineoplastic (bladder cancer)
0,209  0,047  LDLR expression enhancer
0,198  0,041  Antineoplastic (bone cancer)
0,197  0,040  Heat shock protein 90 antagonist
0,270  0,118  CYP3A4 substrate
0,191  0,040  Carcinogenic, group 1
0,155  0,006  Phosphodiesterase VI inhibitor
0,211  0,065  Abortion inducer
0,230  0,084  Antineoplastic (cervical cancer)
0,207  0,062  CYP2B6 inhibitor
0,186  0,042  Genotoxic
0,155  0,011  Beta tubulin antagonist
0,158  0,018  DOPA decarboxylase inhibitor
0,155  0,017  Antiprotozoal (Toxoplasma)
0,134  0,004  Endothelin A receptor antagonist
0,209  0,080  Antiparkinsonian, rigidity relieving
0,243  0,114  Hepatic disorders treatment
0,156  0,030  Alpha 2c adrenoreceptor antagonist
0,180  0,055  Cystic fibrosis treatment
0,127  0,004  Vesicle monoamine transporter inhibitor
0,175  0,054  Antiischemic, cerebral
0,167  0,047  Antifungal enhancer
0,122  0,004  Endothelin B receptor antagonist
0,143  0,030  Sphingosine 1-phosphate receptor 2 agonist
0,117  0,005  Glutamate (mGluR7) antagonist
0,142  0,030  Alpha 2 adrenoreceptor antagonist
0,163  0,051  Renal failure treatment
0,180  0,069  Sigma receptor agonist
0,149  0,038  MAO B inhibitor
0,147  0,036  Antiviral (Papilloma)
0,128  0,019  Phosphodiesterase 6D inhibitor
0,140  0,031  Obsessive-compulsive disorder treatment
0,175  0,066  Heat shock protein 90 alpha antagonist
0,183  0,077  Hepatoprotectant
0,176  0,070  Tumour necrosis factor antagonist
0,182  0,078  P-glycoprotein inhibitor
0,156  0,052  Acetylcholinesterase inhibitor
0,203  0,099  NOS2 expression inhibitor
0,176  0,072  Chemopreventive
0,131  0,029  Calcium antagonist
0,211  0,111  Proliferative diseases treatment
0,132  0,033  Antineoplastic alkaloid
0,190  0,091  Antihypertriglyceridemic
0,126  0,028  Topoisomerase II alpha inhibitor
0,163  0,066  Melanin inhibitor
0,129  0,034  Breast cancer-resistant protein inhibitor
0,182  0,091  Psychostimulant
0,110  0,020  Caspase 7 inhibitor
0,105  0,014  5 Hydroxytryptamine 5A antagonist
0,252  0,163  TNF expression inhibitor
0,223  0,134  Bone diseases treatment
0,210  0,122  CYP2C19 substrate
0,165  0,077  ATPase inhibitor
0,098  0,011  Leukotriene B4 antagonist
0,101  0,015  5 Hydroxytryptamine 5 antagonist
0,129  0,043  Activin receptor-like kinase 4 inhibitor
0,135  0,051  Papain-like protease (SARS coronavirus) inhibitor
0,283  0,200  MAP kinase 1 inhibitor
0,101  0,021  Leukotriene antagonist
0,161  0,082  Catenin beta inhibitor
0,126  0,052  Shock treatment
0,126  0,053  Alpha 2b adrenoreceptor antagonist
0,121  0,052  MAO A inhibitor
0,221  0,152  Antineoplastic (osteosarcoma)
0,105  0,038  Restless leg syndrome treatment
0,184  0,117  Cytostatic
0,100  0,035  Granulocyte macrophage colony stimulating factor agonist
0,091  0,026  Transforming growth factor antagonist
0,070  0,007  Diamine oxidase inhibitor
0,189  0,125  DNA damaging
0,075  0,012  Ryanodine receptor antagonist
0,130  0,068  Antibacterial (Helicobacter pylori)
0,193  0,134  Antituberculosic
0,096  0,038  5 Hydroxytryptamine 1 antagonist
0,252  0,195  Antiarthritic
0,159  0,102  Amyloid beta aggregation inhibitor
0,064  0,008  Acid-sensing ion channel blocker
0,147  0,093  Muscle relaxant
0,085  0,032  Antitreponemal
0,081  0,029  Endocannabinoid uptake inhibitor
0,075  0,024  Heat shock protein 90 beta antagonist
0,161  0,111  Antimitotic
0,113  0,063  5 Hydroxytryptamine 2 antagonist
0,120  0,072  DNA repair enzyme inhibitor
0,095  0,048  ATPase (Vacuolar H+) inhibitor
0,051  0,005  Bombesin agonist
0,132  0,087  Skeletal muscle relaxant
0,093  0,050  Phosphodiesterase IV inhibitor
0,189  0,146  Antineoplastic (sarcoma)
0,046  0,005  Bombesin 3 receptor agonist
0,055  0,013  Phosphodiesterase 6C inhibitor
0,093  0,051  Carcinogenic, group 2A
0,111  0,070  5 Hydroxytryptamine antagonist
0,127  0,088  Vascular endothelial growth factor 3 antagonist
0,100  0,062  Butyrylcholinesterase inhibitor
0,091  0,052  5 Hydroxytryptamine 2A antagonist
0,164  0,127  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,088  0,051  Histamine H2 receptor antagonist
0,041  0,005  Integrin alphaVbeta1 antagonist
0,102  0,066  Carcinogenic, group 2B
0,072  0,036  Dopamine D3 antagonist
0,058  0,022  Phosphodiesterase X inhibitor
0,058  0,022  Phosphodiesterase 10A inhibitor
0,068  0,036  Protease activated receptor antagonist
0,050  0,018  Dihydrofolate reductase inhibitor
0,133  0,103  MAP kinase kinase 4 inhibitor
0,127  0,099  Cholinergic
0,040  0,012  Thrombin receptor antagonist
0,077  0,053  Nicotinic alpha4beta2 receptor antagonist
0,229  0,205  DNA polymerase beta inhibitor
0,072  0,048  Peroxisome proliferator-activated receptor gamma antagonist
0,099  0,075  Choleretic
0,131  0,108  Pulmonary hypertension treatment
0,100  0,078  Multidrug resistance-associated protein 1 inhibitor
0,096  0,073  Folate antagonist
0,083  0,062  mTOR complex 2 inhibitor
0,050  0,029  Carnitine palmitoyltransferase 1B inhibitor
0,050  0,031  AMPA receptor antagonist
0,028  0,008  Imidazoline I1 receptor antagonist
0,150  0,132  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,028  0,009  Integrin beta5 antagonist
0,034  0,016  Phosphodiesterase 6B inhibitor
0,064  0,047  5 Hydroxytryptamine 1B antagonist
0,103  0,086  Microtubule formation inhibitor
0,053  0,036  Melanin-concentrating hormone receptor 1 antagonist
0,102  0,086  Cell adhesion inhibitor
0,089  0,074  Vascular endothelial growth factor 1 antagonist
0,018  0,005  Integrin beta6 antagonist
0,182  0,170  Antimycobacterial
0,195  0,182  Vasodilator, peripheral
0,219  0,207  Alpha-glucosidase inhibitor
0,030  0,018  Leukotriene B4 receptor 1 antagonist
0,058  0,046  Alpha 2 adrenoreceptor agonist
0,158  0,146  Vasodilator
0,125  0,114  Adenylate cyclase stimulant
0,063  0,052  Orexin receptor antagonist
0,153  0,143  Antiamyloidogenic
0,140  0,130  Non-steroidal antiinflammatory agent
0,219  0,210  Transcription factor inhibitor
0,066  0,058  Dopamine antagonist
0,123  0,115  CDC-like kinase 2 inhibitor
0,065  0,057  Anticholelithogenic
0,024  0,016  Phosphodiesterase 6G inhibitor
0,024  0,016  Phosphodiesterase 6H inhibitor
0,026  0,019  Sodium/glucose cotransporter 2 inhibitor
0,023  0,017  Phosphodiesterase 6A inhibitor
0,201  0,195  Stroke treatment
0,099  0,093  Antiseptic
0,012  0,006  Imidazoline I2 receptor antagonist
0,085  0,079  Sphingomyelinase inhibitor
0,133  0,128  Wound healing agent
0,021  0,016  Integrin alphaVbeta3 antagonist
0,038  0,035  Plasmepsin II inhibitor
0,103  0,099  Cyclooxygenase 3 inhibitor
0,058  0,055  5 Hydroxytryptamine 1A antagonist
0,020  0,017  Glutaminyl-peptide cyclotransferase inhibitor
0,042  0,039  Potassium channel Kv1.3 blocker
0,077  0,074  Alpha adrenoreceptor antagonist
0,016  0,014  Vesicular glutamate transport inhibitor
0,150  0,148  Fibrosis treatment
0,122  0,119  Neuropeptide Y1 antagonist
0,104  0,102  Bone formation stimulant
0,173  0,171  Antiischemic
0,158  0,156  Spasmolytic
0,162  0,161  Antiosteoporotic
0,043  0,043  Transforming growth factor beta 1 antagonist

